Healthcare News

FDA Fast Track Designation underscores the urgency of developing new treatment options and the potential of SOT106 to address a significant medical need.

Odyssey Therapeutics will participate in three upcoming global healthcare investor conferences this September, each featuring a fireside chat discussion.

CoreHealth acquires Konnected, expanding its wellness expertise and program delivery capabilities to better support clients.

- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here, which indicated treatment with acoramidis may improve cardiac structure and function with...

MILLBRAE, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to...

MicrobiotiX completes MP101's sentinel cohort, with no safety concerns preventing continuation of its first-in-human Phase 1 pneumonia trial.

Professor Marlies Wijsenbeek will give an oral presentation on the quality-of-life outcomes assessed by the LCQ from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with...

WALTHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate...

Orphan Drug Designation application and pre-MAA Scientific Advice package submitted for Ebstrocel™ in RDEBFilings support a planned EU MAA in Q1 2027; orphan designation, if granted and maintained...

Ligand to Participate in September Investor Conferences